Skip to main content
Premium Trial:

Request an Annual Quote

Fluxergy Nabs CE-IVD Mark for SARS-CoV-2 POC PCR Test

NEW YORK – Diagnostic startup Fluxergy announced on Thursday that its COVID-19 RT-PCR test has received CE-IVD marking.

The Irvine, California-based company's automated, sample-to-answer Fluxergy Diagnostic Testing System has the ability to run multiple different assay types at the same time, such as molecular, immunochemistry, cytometry, and chemistry tests, on the same cartridge. The Fluxergy COVID-19 Sample-to-Answer-RT-PCR test returns results in one hour.

The firm is now seeking commercial partnerships with healthcare providers and "potential international go-to-market partners in Europe, Asia, and Australia," CCO Ali Tinazli said in a statement. The company has expanded manufacturing capabilities for the testing system to 1 million tests per month, it said in a statement.

Fluxergy had previously made its platform available for research use only with its partners, including University of California, San Diego and Mass General Brigham.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.